Imagion Biosystems Limited (ASX:IBX)
Australia · Delayed Price · Currency is AUD 0.0300
+0.0010 (3.45%)
Sep 11, 2025, 11:36 AM AEST
Imagion Biosystems Market Cap
Imagion Biosystems has a market cap or net worth of 7.14 million as of September 10, 2025. Its market cap has increased by 423.41% in one year.
Market Cap
7.14M
Enterprise Value
9.56M
Revenue
1.06M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.03
Market Cap Chart
Since June 22, 2017, Imagion Biosystems's market cap has decreased from 32.65M to 7.14M, a decrease of -78.12%. That is a compound annual growth rate of -16.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2025 | 7.14M | 54.27% |
| Dec 31, 2024 | 4.63M | -60.04% |
| Dec 29, 2023 | 11.59M | -56.93% |
| Dec 30, 2022 | 26.91M | -68.41% |
| Dec 31, 2021 | 85.20M | -41.15% |
| Dec 31, 2020 | 144.76M | 1,032.55% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 22, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 102.19B |
| Pro Medicus | 31.05B |
| Cochlear | 19.66B |
| Sonic Healthcare | 11.22B |
| Ramsay Health Care | 7.72B |
| Ansell | 4.91B |
| Telix Pharmaceuticals | 4.88B |
| Mesoblast | 2.96B |